跳至主要内容
临床试验/EUCTR2015-003073-15-GB
EUCTR2015-003073-15-GB进行中(未招募)1 期

HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) - HYDRA-P

Research Governance, University of Leicester0 个研究点目标入组 58 人开始时间: 2019年3月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients who:
  • 1. Undergo an elective endovascular infra-renal abdominal aortic aneurysm repair, for a non-ruptured or leaking aneurysm
  • 2. Are above the age of 18 years
  • 3. Are able to provide informed consent for the EVAR and participation in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • 1.Emergency abdominal aortic aneurysm repair
  • 2.Leaking or ruptured aneurysm
  • 3.Age<18 years
  • 4.Established cardiac failure with functional status >NYHA III (severe heart failure)
  • 5.Allergy to contrast medium or sodium bicarbonate
  • 6.Pregnancy or lactation (pregnancy test is standard practice at baseline)
  • 7.Juxtarenal or suprarenal aneurysm
  • 8.Solitary kidney
  • 9.Administration of intra-venous or intra-arterial contrast <2 days prior to EVAR
  • 10.Previous open AAA or iliac aneurysm repair
  • 11.Surgery within 1 month before EVAR
  • 12.Major trauma within 1 month before EVAR
  • 13.Established metabolic or respiratory alkalosis
  • 14.Patient receiving chemotherapy, radiotherapy or steroid therapy
  • 15.Life expectancy less than 1 year
  • 16.Patient undergoing renal dialysis for established renal failure
  • 17.Patient receiving nephrotoxic medication for 48 hours prior to EVAR
  • 18.Patient unwilling or unable to provide informed consent
  • 19.Participation in other interventional clinical trial 1 month prior to commencing HYDRA-P
  • 20.Established pulmonary oedema at baseline
  • 21.Hyperventilation
  • 22.Hypernatraemia
  • 23.Systolic blood pressure exceeding 200mHg at baseline
  • 24.Unable to understand and provide consent in English.

研究者

发起方
Research Governance, University of Leicester

相似试验